- $94.97m
- $65.85m
- 29
- 54
- 59
- 44
Annual cashflow statement for Instil Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.7 | -157 | -223 | -156 | -74.1 |
| Depreciation | |||||
| Non-Cash Items | 6.39 | 27.5 | 46.6 | 78.3 | 27.4 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.48 | 4.36 | -9.57 | -9.02 | -12.6 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -29.6 | -122 | -180 | -82 | -55.7 |
| Capital Expenditures | -50.8 | -57.8 | -84.6 | -20.7 | -10 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.306 | -417 | 199 | 61.8 | 64 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.1 | -474 | 115 | 41.1 | 54 |
| Financing Cash Flow Items | 0.065 | -0.069 | 0 | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 313 | 393 | 71.9 | 8.08 | 1.75 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 233 | -204 | 5.63 | -33 | -0.061 |